Novartis Ag (NVS) Profit After Tax (2009 - 2025)
Novartis Ag (NVS) posted Profit After Tax of $4.0 billion for Q2 2025, up 285390070821.99% sequentially from $1.41 in Q4 2024, and up 23.97% YoY from $3.2 billion in Q2 2024.
Novartis Ag (NVS) Profit After Tax (2009 - 2025) Analysis & Trends
Novartis Ag (NVS) has 15 years of Profit After Tax data on file, last reported at $4.0 billion in Q2 2025.
- Quarterly Profit After Tax rose 23.97% year-over-year to $4.0 billion in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $7.3 billion (up 123.97% YoY) and the FY2025 annual result came in at $14.0 billion, up 16.99% from the prior year.
- Profit After Tax grew to $4.0 billion in Q2 2025 per NVS's latest filing, from $1.41 in the prior quarter.
- The five-year high for Profit After Tax was $34001.4 billion in Q1 2022, with the low at $0.61 in Q3 2022.
- Average Profit After Tax over 5 years is $2001.4 billion, with a median of $1.3 billion recorded in 2021.
- Year-over-year, Profit After Tax jumped 538478260769.57% in 2021 and slumped 100.0% in 2023.
- Novartis Ag's Profit After Tax stood at $5.0 billion in 2021, then tumbled by 100.0% to $0.61 in 2022, then soared by 109.84% to $1.28 in 2023, then climbed by 10.16% to $1.41 in 2024, then surged by 285390070821.99% to $4.0 billion in 2025.
- Business Quant data shows NVS's Profit After Tax at $4.0 billion in Q2 2025, $1.41 in Q4 2024, and $1.57 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 7.40 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 5.24 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 697.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 3.08 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -4.24 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.82 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 2.02 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.71 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | 319.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4.02 Bn |
| Dec 31, 2024 | 1.41 |
| Sep 30, 2024 | 1.57 |
| Jun 30, 2024 | 3.25 Bn |
| Mar 31, 2024 | 1.31 |
| Dec 31, 2023 | 1.28 |
| Sep 30, 2023 | 0.73 |
| Jun 30, 2023 | 2.32 Bn |
| Mar 31, 2023 | 1.01 |
| Dec 31, 2022 | 0.61 |
| Sep 30, 2022 | 0.61 |
| Jun 30, 2022 | 1.70 Bn |
| Mar 31, 2022 | 1.41 Bn |
| Dec 31, 2021 | 4.95 Bn |
| Sep 30, 2021 | 1.40 Bn |
| Jun 30, 2021 | 2.90 Bn |
| Mar 31, 2021 | 14,001.31 Bn |
| Dec 31, 2020 | 0.92 |
| Sep 30, 2020 | 0.84 |
| Jun 30, 2020 | 1.87 Bn |